MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/850/0.01/20.09.24 Stock

Warrant

DE000ME8HMS4

Market Closed - Börse Stuttgart 11:58:18 2024-06-27 EDT
0.036 EUR +2.86% Intraday chart for MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/850/0.01/20.09.24
Current month+2.86%
1 month+38.46%
Date Price Change
24-06-27 0.036 +2.86%
24-06-26 0.035 +12.90%
24-06-25 0.031 -3.13%
24-06-24 0.032 +68.42%
24-06-21 0.019 0.00%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 11:58 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying IDEXX LABORATORIES, INC.
Issuer Morgan Stanley
WKN ME8HMS
ISINDE000ME8HMS4
Date issued 2024-02-09
Strike 850 $
Maturity 2024-09-20 (85 Days)
Parity 100 : 1
Emission price 0.08
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.097
Lowest since issue 0.019
Spread 0.021
Spread %36.84%

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
494 USD
Average target price
564.1 USD
Spread / Average Target
+14.21%
Consensus